{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:43:50Z","timestamp":1786221830692,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T00:00:00Z","timestamp":1699142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["K43 TW012350"],"award-info":[{"award-number":["K43 TW012350"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D8111C00013 \/ ESR-21-21311"],"award-info":[{"award-number":["D8111C00013 \/ ESR-21-21311"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"AstraZeneca UK Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-033558"],"award-info":[{"award-number":["INV-033558"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012566","name":"Tindall Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijregi.2023.11.002","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T14:34:11Z","timestamp":1699626851000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study \u2013 final study results"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0017-2438","authenticated-orcid":false,"given":"Joseph","family":"Makhema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9288-7881","authenticated-orcid":false,"given":"Emily","family":"Shava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-7223","authenticated-orcid":false,"given":"Alane","family":"Izu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tendani","family":"Gaolathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesego","family":"Kuate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Carty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coulson","family":"Kgathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7606-0569","authenticated-orcid":false,"given":"Wonderful T.","family":"Choga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumalano","family":"Sekoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngozana","family":"Seonyatseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4156-8746","authenticated-orcid":false,"given":"Tuelo","family":"Mogashoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2528-7469","authenticated-orcid":false,"given":"Comfort N.","family":"Maphorisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tshenolo","family":"Ntalabgwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tshepho T.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boitumelo","family":"Matlhaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ame","family":"Diphoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thandie","family":"Phindela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agripa","family":"Kaunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poloko","family":"Kgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2079-4886","authenticated-orcid":false,"given":"Thomas","family":"Kanyakula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gape","family":"Palalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Phakedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mompati","family":"Mmalane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikhulile","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2023.11.002_bib0001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0002","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0003","series-title":"Country progress report-Botswana","year":"2020"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0004","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/S2352-3018(16)00037-0","article-title":"Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey","volume":"3","author":"Gaolathe","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s41256-022-00255-1","article-title":"COVID-19 vaccine hesitancy in Africa: a scoping review","volume":"7","author":"Ackah","year":"2022","journal-title":"Glob Health Res Policy"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0006","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jinf.2023.02.037","article-title":"Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana","volume":"86","author":"Shava","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0007","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/oxfordjournals.aje.a115507","article-title":"A simple method to calculate the confidence interval of a standardized mortality ratio (SMR)","volume":"131","author":"Ulm","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0008","first-page":"274","article-title":"Theory of point estimation","volume":"41","year":"1999","journal-title":"Technometrics"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0009","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0010","article-title":"COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study","volume":"12","author":"Xueying","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0011","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-022-00452-6","article-title":"Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy","volume":"7","author":"Brumme","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0012","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000519456","article-title":"Adverse events following AstraZeneca COVID-19 vaccine in Saudi Arabia: a cross-sectional study among healthcare and nonhealthcare workers","volume":"65","author":"Alghamdi","year":"2022","journal-title":"Intervirology"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.40364","article-title":"Analysis of COVID-19 vaccine type and adverse effects following vaccination","volume":"4","author":"Beatty","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0015","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/cid\/ciac852","article-title":"Adverse events following immunization with mRNA and viral vector vaccines in individuals with previous severe acute respiratory syndrome coronavirus 2 infection from the Canadian national vaccine safety network","volume":"76","author":"Bettinger","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0016","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1038\/s41467-022-33792-x","article-title":"SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa","volume":"13","author":"Abdullahi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0017","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJMoa2119658","article-title":"Population immunity and Covid-19 severity with omicron variant in South Africa","volume":"386","author":"Madhi","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0018","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/cei\/uxad013","article-title":"Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials","volume":"211","author":"Voysey","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0019","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1093\/cid\/ciac262","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) naturally acquired immunity versus vaccine-induced immunity, reinfections versus breakthrough infections: a retrospective cohort study","volume":"75","author":"Gazit","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1473-3099(22)00596-5","article-title":"Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial","volume":"23","author":"Madhi","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijid.2023.01.022","article-title":"Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants","volume":"129","author":"Niyomnaitham","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijregi.2023.11.002_bib0022","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMoa2116414","article-title":"Homologous and heterologous Covid-19 booster vaccinations","volume":"386","author":"Atmar","year":"2022","journal-title":"N Engl J Med"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707623001091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707623001091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:12:26Z","timestamp":1786219946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707623001091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":22,"alternative-id":["S2772707623001091"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2023.11.002","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study \u2013 final study results","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2023.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}